Reaction of (R)-(-)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) with guanosine

The reaction of a new antitumor platinum complex, (R)-(-)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato++ +)platinum(II) (1) with guanosine at room temperature in an aqueous solution was followed by proton nuclear magnetic resonance (1H-NMR) spectroscopy and high performance liquid chromatography (HPLC) at intervals. Both techniques showed that a new compound was formed by displacement of the 1,1-cyclobutanedicarboxylate moiety of 1 with two guanosines, and its 1H-NMR spectrum and HPLC chromatogram were proved to be identical with those of [(R)-(-)-2-aminomethylpyrrolidine]bis(N7-guanosine)platinum(II) (2), which was obtained upon successive treatment of (R)-(-)-2-aminomethylpyrrolidinedichloroplatinum(II) (3) with AgNO3 and 2 mol eq of guanosine in water. The binding sites of the platinum to the two guanosine moieties in 2 were confirmed by the pH dependence of the two G-H8 signals.     

Synthesis and characterization of platinum(II) complexes with 2-imidazolidinethione. X-ray crystal structure of tetra(2-imidazolidinethione- S )platinum(II) iodide dimethylsulfoxide solvate monohydrate

Preparations of trans-[PtX₂(Imt)₂] (Imt =?2-imidazolidinethione, X=Cl^? or I^?) and [Pt(Imt)₄]I₂ are described. These complexes were characterized by elemental analysis, thermal analysis, mid- and far-IR spectroscopy, and NMR (¹H and ¹³C) spectroscopy. The crystal and molecular structure of [Pt(Imt)₄]I₂ ·?DMSO ·?H₂O was determined by X-ray diffraction methods. The structural data reveal the following features: (a) the platinum atom in [Pt(Imt)₄]²⁺ is essentially in a square-planar environment, (b) the entire dication possesses approximately C _2h symmetry, (c) no appreciable hydrogen bonding exists between the iodide ions and the Imt ligands in the dication, (d) two pairs of two mutually cis Imt ligands are arranged above and below the PtS₄ plane, respectively, and (e) two planes defined by two trans Imt rings are perpendicular to each other.     

Coordination compounds of palladium(II) and platinum(II) with benzotriazoles

Summary The nitrogen-donor ligands 1-methylbenzotriazole (1Mebta), 5-methylbenzotriazole (5MebtaH), 5-chlorobenzotriazole (5ClbtaH) and 5-nitrobenzotriazole (5NO₂btaH) react with palladium(II) and platinum(II) to give cis-[PdL₂Cl₂], cis-[PtL₂Cl₂] (L = 1Mebta, 5MebtaH, 5ClbtaH or 5NO₂btaH), [Pt(5ClbtaH)₄]Cl₂, [Pd-(5MebtaH)Cl₂]₂, [Pd(5ClbtaH)Cl₂]₂ and [Pd(5NO₂btaH)-Cl₂]₂. The complexes were characterized by physicochemical and spectroscopic methods. The benzotriazoles act as monodentate ligands binding through N(3). Monomeric square planar structures are assigned for the 12 complexes and [Pt(5ClbtaH)₄]Cl₂ in the solid state. Centrosymmetric, chloro-bridged, dinuclear square planar structures of C_2h symmetry are proposed for the 11 palladium(II) compounds.     

Synthesis and antiproliferative activity of (1R,2R)-N1-(2-butyl)-1,2-cyclohexanediamine platinum(II) complexes with malonate derivatives

Three new platinum(II) complexes of (1R,2R)-N¹-(2-butyl)-1,2-cyclohexanediamine with malonate derivatives as leaving groups have been synthesized and spectrally characterized. They were tested in vitro against four human cancer cell lines. [(1R,2R)-N¹-(2-butyl)-1,2-cyclohexanediamine-N,N′](2-ethylmalonato-O,O′)platinum(II) turned out to be more active (IC₅₀ = 4.65 μM) than oxaliplatin (IC₅₀ = 6.55 μM) against the MCF-7 cell line and is superior to its parent complex, [(1R,2R)-N¹-(2-butyl)-1,2-cyclohexanediamine-N,N′](malonato-O,O′)platinum(II). In addition, agarose gel electrophoresis study revealed that the interaction of the complex with pET22b plasmid DNA had a different behavior from that of cisplatin or oxaliplatin.     

Facile generation of platinum(IV) compounds with mixed labile moieties. Hydrogen peroxide oxidation of platinum(II) to platinum(IV) compounds

Hydrogen peroxide oxidation of platinum(II) compounds containing labile groups such as Cl, OH, and alkene moieties has been carried out and the products characterized. The reactions of [Pt^II (X)₂ (N–N)] (X = Cl, OH, X₂ = isopropylidenemalorate (ipm); N–N 2,2-dimethyl-1,3-propanediamine [(dmpda), N-isopropyl-1,3-propanediamine (ippda)] with hydrogen peroxide in an appropriate solvent at room temperature affords [Pt^IV (OH)(Y)(X)₂(N–N)] (Y = OH, OCH₃). The crystal structures of [Pt^IV(OH)(OCH₃)(Cl)₂(dmpda)]·2H₂O (P-1 bar, a = 6.339(2) Å , b = 9.861(1) Å, c = 11.561(1) Å, a = 92.078(9)°, β = 104.78(1)°, γ=100.54(1)°, V = 684.3(2) ų, Z = 2R = 0.0503) and [Pt^IV(OH)₂(ipm)(ippda)]·3H₂O (C 2/c, a = 27.275(6) Å, b=6.954(2) Å, c = 22.331(4) Å, β = 118.30(2)°, V = 3729(2) ų, Z = 8, R = 0.0345) have been solved and refined. The local geometry around the platinum(IV) atom approximates to a typical octahedral arrangement with two added groups (OH and OCH₃; OH and OH) in a transposition. The platinum(IV) compounds with potential labile moieties may be important intermediate species for further reactions.     

Electrochemistry of platinum(II) coordination compounds II. Electroreduction of trimetallic dimetalliobis(isocyanide)platinum(II) complexes

Linear trimetallic MPPt^IIL₂M complexes (M = Cr(CO)₃(η-C₅H₅), Mo(CO)₃- (η-C₅H₅), W(CO)3(η-C₅-H₅), Mn(CO)₅, Fe(CO)₃NO, Co(CO)₄; L = t-BuNC, cyclo- C₀H₁₁ NC) are reduced on platinum and gold electrodes in non-aqueous medium. All these complexes undergo irreversible one electron reductions, which result in the rupture of one Ptmetal bond and the liberation of one M^? ion per mole reduced. Coupled ESR spectroscopy and coulometry show that a radical is generated during the reduction of the trimetallic complexes. The several ESR signals obtained for these paramagnetic Pt¹ species exhibit no hyperfine structure.The electrochemical behaviour of MPtL₂M complexes is compared with that of the following linear trimetallic complexes: MHgM and (MAuM)^?.     

Coordination complexes of l-azetidine-2-carboxylic acid with platinum(II) and palladium(II)

Summary The complexes K[Pt(l-aze)Cl₂, [Pt(l-aze)₂] and [Pd(l-aze)₂] (l-aze = l-azetidine-2-carboxylate) were prepared. X-ray structures show that [Pt(l-aze)₂] and [Pd(l-aze)₂] are isomorphous, having a planar tetragonal geometry with a trans configuration around the Pt and Pd atoms. Slight puckerings of the MN(1)N(11)O(11) chelate ring (M = Pt or Pd) and the azetidine ring were observed. The circular dichroism (c.d.) spectra of the complexes in aqueous solution agree with the structures found in the solid state as far as the hexadecant rule is concerned, giving, for the trans configuration of [M(l-ia)₂] (where ia = imino acid), the profile of the c.d. signs for the three predominant d-d transitions as: +,-,-. I.r., conductivity and n.m.r. measurements are also reported and are in accord with the proposed structures.     

1,1-ethylenedithiolato complexes of palladium(II) and platinum(II) with isocyanide and carbene ligands

The reactions of [Tl(2)[S(2)C=C[C(O)Me](2)]](n) with [MCl(2)(NCPh)(2)] and CNR (1:1:2) give complexes [M[eta(2)-S(2)C=C[C(O)Me](2)](CNR)(2)] [R = (t)Bu, M = Pd (1a), Pt (1b); R = C(6)H(3)Me(2)-2,6 (Xy), M = Pd (2a), Pt (2b)]. Compound 1b reacts with AgClO(4) (1:1) to give [[Pt(CN(t)Bu)(2)](2)Ag(2)[mu(2),eta(2)-(S,S')-[S(2)C=C[C(O)Me](2)](2)]](ClO(4))(2) (3). The reactions of 1 or 2 with diethylamine give mixed isocyanide carbene complexes [M[eta(2)-S(2)C=C[C(O)Me](2)](CNR)[C(NEt(2))(NHR)]] [R = (t)Bu, M = Pd (4a), Pt (4b); R = Xy, M = Pd (5a), Pt (5b)] regardless of the molar ratio of the reagents. The same complexes react with an excess of ammonia to give [M[eta(2)-(S,S')-S(2)C=C[C(O)Me](2)](CN(t)Bu)[C(NH(2))(NH(t)Bu)]] [M = Pd (6a), Pt (6b)] or [M[eta(2)-(S,S')-S(2)C=C[C(O)Me](2)][C(NH(2))(NHXy)](2)] [M = Pd (7a), Pt (7b)] probably depending on steric factors. The crystal structures of 2b, 4a, and 4b have been determined. Compounds 4a and 4b are isostructural. They all display distorted square planar metal environments and chelating planar E,Z-2,2-diacetyl-1,1-ethylenedithiolato ligands that coordinate through the sulfur atoms.     

Synthesis, structure and antitumor activity of a water-soluble platinum complex, (1R,3R,4R,5R)-(-)-quinato(1R,2R-cyclohexanediamine)platinum (II).

The reaction of dihydroxo(1R,2R-cyclohexanediamine)platinum(II) with (-)-quinic acid gave a water soluble complex, (-)-quinato(1R,2R-cyclohexanediamine)platinum(II). The crystal structure of the complex was determined by X-ray analysis. The data indicate a chelation of the alpha-hydroxycarboxylic acid part of quinic acid to platinum(II). The complex shows moderate antitumor activity against murine leukemia L1210 at high doses (T/C x 100 = 179% at a dose of 200 mg/kg).     

Polymorphs with varying platinum(II)-thallium(I) interactions

TlI[(C4H9N4)PtII(CN)2] forms a red, crystalline polymorph in which the ions are arranged to form an extended ...Pt...Tl...Pt...Tl... chain (Pt...Tl distance, 3.0978(2) A; Pt-Tl-Pt and Tl-Pt-Tl angles, (171.37(2) degrees ) and a yellow polymorph in which dimers are connected by pairs of Pt...Tl interactions with a Pt...Tl distance of 3.0256(5) A.     

Bromination of sydnones. II Bromination of 3-(2-aminophenyl)sydnone and related compounds

Bromination of 3-(2-aminophenyl)sydnone 2 under a variety of conditions is reported. The products obtained are interrelated by a series of subsequent reactions. One major product is the bromoaryl compound 8, the first example of bromination on the aryl rather than sydnone ring when the two are in competition. Surprisingly, bromoaminosydnone 9, prepared from its nitro analogue, was not among the products obtained by direct bromination of 2.     

Synthesis, reactivity and crystal structures of platinum (II) and platinum (IV) cyclometallated compounds derived from 2- and 4-biphenylimines

The reaction of [Pt₂Me₄(μ-SMe₂)₂] with ligands 4-C₆H₅C₆H₄CHNCH₂CH₂NMe₂ (1a) and 2-C₆H₅C₆H₄CHNCH₂CH₂NMe₂ (1b) carried out in acetone at room temperature produced compounds [PtMe₂{4-C₆H₅C₆H₄CHNCH₂CH₂NMe₂}] (2a) and [PtMe₂{2-C₆H₅C₆H₄CHNCH₂CH₂NMe₂}] (2b), respectively, in which the imines act as bidentate [N,N′] ligands. Cyclometallated [C,N,N′] compounds [PtMe{4-C₆H₅C₆H₃CHNCH₂CH₂NMe₂}] (3a) and [PtMe{2-C₆H₅C₆H₃CHNCH₂CH₂NMe₂}] (3b), were obtained by refluxing toluene solutions of compounds 2a or 2b. Reaction of [Pt₂Me₄(μ-SMe₂)₂] with ligands 4-C₆H₅C₆H₄CHNCH₂Ph (1c) and 2-C₆H₅C₆H₄CHNCH₂Ph (1d) produced compounds [PtMe{4-C₆H₅C₆H₃CHNCH₂Ph}SMe₂] (5c) and [PtMe{2-C₆H₅C₆H₃CHNCH₂Ph}SMe₂] (5d) containing a [C,N] ligand, from which triphenylphosphine derivatives 6c and 6d were also prepared. In all cases, metallation took place to yield five-membered endo-metallacycles and formation of seven-membered or of exo-metallacycles was not observed. The reactions of 3a, 3b, 6c and 6d with methyl iodide were studied in acetone and gave the corresponding cyclometallated platinum (IV) compounds. All compounds were characterised by NMR spectroscopy and compounds 3b, 4a, 6c and 6d were also characterised crystallographically.     

Trace-element levels in tissues of rats and dogs treated with cis-diammine/1,1-cyclobutanedicarboxylato/platinum/II/ /Carboplatin/

Platinum and eleven other trace elements were determined by radiochemical neutron activation analysis in tissues of healthy rats and dogs treated with the anti-cancer drug carboplatin. In rats the levels of the trace elements were not much influenced; in the kidney only the Co and the Sb levels were decreased and in the liver only the Mo level was increased. A parallel tendency in the Co and Mo metabolism was seen in dogs. Carboplatin treatment tends to reduce the Cd, Co and Fe levels in metabolic active organs, kidney, liver, spleen and/or pancreas of the dog.     

Symmetries of deoxyribonucleic acid (DNA) and related molecules

The basic groups and some atomic groups in polynucleotide long-chains of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) have been used as the basic structural unit to analyze their molecular symmetry. The basic groups have been treated as the same structural unit in spite of the fact that they have very different intrinsic characteristics. In this paper, we developed bi-double-valued H- and P-representations to distinguish between the various structural units in DNA and RNA. We simulated their molecular symmetries based on our earlier work on the symmetry analysis of cylinder and torus carbon nanotubes. The symmetric and antisymmetric components of some gene segments with some transformations have been calculated in the bi-double-valued HP-representation space. By analyzing the genetic code table, we investigated the distributive features of codons in corresponding H- and P-representations. The results indicate that some characteristics of H- and P-representation carry messages of the corresponding genetic processes in DNA. In addition, we analyzed some topologic features and Möbius twists of torus groups for circular DNA.     

Synthesis,cytotoxicity, and interaction with DNA of platinum(II) complexes of (1R,2R)-N1-2-amyl-1,2-diaminocyclohexane

(1R,2R)-N¹-2-amyl-1,2-diaminocyclohexane, which has an amyl substituent as compared with 1,2-diaminocyclohexane, was used as the carrier group to construct three platinum(II) complexes. MTT assay revealed that the complexes showed decent cytotoxicity against all of the four tested tumor cell lines with the IC₅₀ values ranging from 1.08 to 253.36 μM. Particularly, the IC₅₀ values of 2 against A549 and HCT-116 reached 3.32 and 1.08 μM, respectively, which were much lower than those of cisplatin and oxaliplatin. Flow cytometry demonstrated that 2 inhibited HepG2 cells proliferation and caused cytotoxicity by inducing apoptosis and arresting cells in the G2 phase. Furthermore, agarose gel electrophoresis showed that 2 had the ability to interact with DNA in a manner different from cisplatin and oxaliplatin, indicating the carrier ligand with an alkyl moiety had an influence on the action mode of the complex.     

Synthesis of 2-(2-methoxyethyl)- and 2-(2-thiomethoxyethyl)-aniline and related compounds

Summary 2-(2-Nitrophenyl)-ethanol (2) was methylated with dimethyl sulfate to give 2-(2-methoxyethyl)-1-nitrobenzene (3a) which then was reduced with hydrazine hydrate in the presence ofRaney nickel to 2-(2-methoxyethyl)-aniline (1a). Compound1a can be transformed into the N-monosilylated derivative4 by lithiation withn-butyllithium and subsequent reaction with chlorotrimethylsilane. Reaction of2 withp-toluenesulfonyl chloride yields 2-(2-nitrophenyl)-ethylp-toluenesulfonate (5), which reacts with sodium thiomethoxide to give 2-(2-nitrophenyl)-ethylp-toluenesulfonate (5), which reacts with sodium thiomethoxide to give 2-(2-thiomethoxyethyl)-1-nitrobenzene (3b).3b was reduced with hydrazine hydrate in the presence ofRaney nickel to yield 2-(2-thiomethoxyethyl)-aniline (1b). Ethyl (2-nitrophenyl)-acetate (6) could be dimethylated with methyl iodide in the presence of potassiumtert-butoxide and 18-crown-6 to give ethyl 2-methyl-2-(2-nitrophenyl)-propionate (7). Reduction of7 with lithium borohydride yields 2,3-dihydro-3,3-dimethyl-1H-indole (9) and 2-[(1-hydroxy-2-methyl)-2-propyl]-aniline (10).

---

Synthese von 2-(2-Methoxyethyl)- und 2-(2-Thiomethoxyethyl)-anilin und verwandten Verbindungen

Zusammenfassung 2-(2-Nitrophenyl)-ethanol (2) wurde mit Dimethylsulfat zu 2-(2-Methoxyethyl)-1-nitrobenzol (3a) methyliert, das sich mit Hydrazinhydrat in Gegenwart vonRaney-Nickel zu 2-(2-Methoxyethyl)-anilin (1a) reduzieren läßt. Verbindung1a kann durch Metallierung mitn-Butyllithium und anschließende Reaktion mit Chlortrimethylsilan in dasN-monosilylierte Derivat4 umgewandelt werden. Reaktion von2 mitp-Toluolsulfonylchlorid ergab 2-(2-Nitrophenyl)-ethyl-p-Toluolsulfonat (5), das mit Natriumthiomethanolat zu 1-Nitro-2-(2-thiomethoxyethyl)-benzol (3b) reagiert.3b wurde mit Hydrazinhydrat in Gegenwart vonRaney-Nickel zu 2-(2-Thiomethoxyethyl)-anilin (1b) reduziert. Ethyl-2-(nitrophenyl)-acetat (6) kann mit Methyliodid in Gegenwart von Kalium-tert-butoxid und 18-Krone-6 zu Ethyl-2-methyl-2-(2-nitrophenyl)-propionat (7) dimethyliert werden. Reduktion von7 mit Lithiumborhydrid lieferte 2,3-Dihydro-3,3-dimethyl-1H-indol (9) und 2-[(1-Hydroxy-2-methyl)-2-propyl]-anilin (10).